Mackenzie Financial Adds $165M in DuPont de Nemours, Inc. ($DD)

Mackenzie Financial significantly increased its investment in DuPont, reflecting a strong interest in the specialty chemicals sector.

Key Points

  • Mackenzie Financial increased its stake in DuPont by 106.7%, adding 1,218,454 shares to hold a total of 2,359,909 shares, valued at $330.4 million.
  • DuPont's stock traded near $140.01 on Wednesday, with a market cap of approximately $19.5 billion and a P/E ratio of 126.8.
  • Recent insider transactions included CEO Lori Koch selling shares, while analysts maintained varied ratings with price targets ranging from $47 to $156.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Mackenzie Financial has boosted its stake in DuPont de Nemours, Inc. (NYSE:DD) by 106.7%, according to its latest 13F filing with the SEC. The fund added 1,218,454 shares during the reporting period, bringing its total holdings to 2,359,909 shares, valued at about $330.4 million.

13F track record

Mackenzie Financial vs. the S&P 500

YTD return +12.65% hypothetical
All-time return +101.51% S&P 500 +82.31%
vs. S&P 500 +19.20% ahead of the index

Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.

What Changed in Mackenzie Financial's DuPont Position

Mackenzie Financial increased its holdings in DuPont from 1,141,455 shares to 2,359,909 shares, adding 1,218,454 shares. This represents a significant 106.7% increase in their position, reflecting an enhanced commitment to the company.

Other Institutional Activity in DuPont

In other institutional activity, BlackRock, Inc. grew its holdings by 116,637 shares, ending with 10,387,631 shares worth about $1.43 billion, marking a 1.1% increase. Vanguard Capital Management LLC and Vanguard Portfolio Management LLC both opened new positions, acquiring 8,864,631 and 6,434,770 shares respectively. State Street Corp increased its stake by 97,151 shares, bringing its total to 6,234,508 shares valued at $856.6 million, a 1.6% increase. In contrast, Invesco Ltd. reduced its holdings by 863,149 shares, now holding 3,975,051 shares, a 17.8% decrease.

DuPont de Nemours, Inc. Stock Down 0.5%

Shares of NYSE:DD traded near $140.01 on Wednesday. DuPont de Nemours, Inc. holds a market cap of approximately $19.5 billion, with a P/E ratio of 126.8 and a forward P/E of 18.4. The stock's 52-week range is between $27.45 and $52.66, and it has a 50-day moving average of $47.62 and a 200-day moving average of $42.31.

Year to date

$DD stock price

Daily closing prices, year to date. Not investment advice.

Recent Earnings

DuPont reported revenue of about $6.92 billion, with a slight growth of 4.3%. The company, however, posted a net margin of -0.42% and a return on equity (ROE) of 0.9%. The next earnings report is scheduled for August 4, 2026.

Earnings drift grade

Outlook vs expectations on the last report — not price action.

C 60/100

Reported May 5, 2026

  1. Forward outlook

    1 analysts raised price targets.

  2. EPS & revenue

    EPS beat estimates by 10.4%. Revenue missed estimates by 2.0%.

  3. Profit surprise

    EBITDA missed by 46 percent. Operating income missed by 52 percent.

  4. Pre-earnings setup

    Bar was high, analysts already very bullish.

  5. Analyst signal

    1 target raise.

  6. Earnings quality

    Gross margin up 3.2 points. Operating margin down 5.0 points. Positive free cash flow.

Earnings Call Summary

DuPont delivered a strong first quarter with organic sales growth of 2 percent and 20 percent adjusted earnings growth on a pro forma basis. Healthcare sales were especially strong at high single digit growth, while water was hampered by about $10 million in shipment delays from Middle East logistics disruptions. Management emphasized continued innovation, with plans to launch an AI platform for product development, and noted steady progress on their operational improvement program including Kaizen events. The company completed the Aramids divestiture and announced a $275 million accelerated share buyback, returning capital to shareholders while maintaining balance sheet strength.

Guidance DuPont raised full year sales guidance to about $7.2 billion and adjusted earnings to $2.35 to $2.40 per share. They expect about 4 percent organic growth for the year, including roughly 1 percent from pricing to cover higher raw material costs from the Middle East conflict. The company also projects strong margin expansion through the rest of the year.

Neutral report. Results and guidance were close to expectations, with limited evidence of a reset either way.

Dividend

DuPont offers an annual dividend rate of $0.80, yielding 1.68%, with a payout ratio of 3.21%.

Insider Buying and Selling at DuPont de Nemours, Inc.

Recent insider activity includes CEO Lori Koch selling 261 shares on June 2, 2026, and 4,673 shares on May 31, 2026. SVP & CFO Antonella Franzen sold 1,558 shares on May 31, 2026. Meanwhile, Alexander Cutler, Frederick Lowery, and Donald Macpherson each purchased shares on May 29, 2026.

Analysts Set New Price Targets

On June 23, 2026, Morgan Stanley maintained a "hold" rating with a $156 price target. UBS and RBC Capital both maintained "buy" ratings with price targets of $59 and $56, respectively. The consensus among 16 analysts is a "buy" rating, with a mean target price of $56.81.

About DuPont de Nemours, Inc.

DuPont de Nemours, Inc., based in Wilmington, Delaware, operates in the specialty chemicals industry. It provides technology-based materials and solutions across various sectors, including healthcare, water technologies, and diversified industrials. The company, led by CEO Lori D. Koch, employs around 15,000 people globally.

Bottom Line

Mackenzie Financial's substantial increase in its DuPont holdings signals a strong interest in the company's potential. Investors track these filings to gauge institutional confidence, though it's essential to remember that 13F filings are backward-looking and may not reflect current positions.

Get DuPont de Nemours, Inc. alerts

New 13F filings, insider trades, and analyst moves on $DD, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.